European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies
Open accessThe DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Abstract
Background and Purpose: This update of the treatment guidelines was commissioned by the European Academy of Neurology and the European section of the Movement Disorder Society. Although these treatments are initiated usually in specialized centers, the general neurologist should know the therapies and their place in the treatment pathway. Methods: Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology was used to assess the spectrum of approved interventions including deep brain stimulation (DBS) or brain lesioning with different techniques (radiofrequency thermocoagulation, radiosurgery, magnetic resonance imaging–guided focused ultrasound surgery [MRgFUS] of the following targets: subthalamic nucleus [STN], ventrolateral thalamus, and pallidum internum [GPi]). Continuous delivery of medication subcutaneously (apomorphine pump) or through percutaneous ileostomy (intrajejunal levodopa/carbidopa pump [LCIG]) was also included. Changes in motor features, health‐related quality of life (QoL), adverse effects, and further outcome parameters were evaluated. Recommendations were based on high‐class evidence and graded in three gradations. If only lower class evidence was available but the topic was felt to be of high importance, clinical consensus of the guideline task force was gathered. Results: Two research questions have been answered with eight recommendations and five clinical consensus statements. Invasive therapies are reserved for specific patient groups and clinical situations mostly in the advanced stage of Parkinson's disease (PD). Interventions may be considered only for special patient profiles, which are mentioned in the text. Therapy effects are reported as change compared with current medical treatment. STN‐DBS is the best‐studied intervention for advanced PD with fluctuations not satisfactorily controlled with oral medications; it improves motor symptoms and QoL, and treatment should be offered to eligible patients. GPi‐DBS can also be offered. For early PD with early fluctuations, STN‐DBS is likely to improve motor symptoms, and QoL and can be offered. DBS should not be offered to people with early PD without fluctuations. LCIG and an apomorphine pump can be considered for advanced PD with fluctuations not sufficiently managed with oral treatments. Unilateral MRgFUS of the STN can be considered for distinctly unilateral PD within registries. Clinical consensus was reached for the following statements: Radiosurgery with gamma radiation cannot be recommended, unilateral radiofrequency thermocoagulation of the pallidum for advanced PD with treatment‐resistant fluctuations and unilateral radiofrequency thermocoagulation of the thalamus for resistant tremor can be recommended if other options are not available, unilateral MRgFUS of the thalamus for medication‐resistant tremor of PD can be considered only within registries, and unilateral MRgFUS of the pallidum is not recommended. Conclusions: Evidence for invasive therapies in PD is heterogeneous. Only some of these therapies have a strong scientific basis. They differ in their profile of effects and have been tested only for specific patient groups. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease
Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schäfer, H., Bötzel, K., Daniels, C., Deutschländer, A., Dillmann, U., Eisner, W., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060281 · Cited by 2,944 · cited 1×
“The most extensively studied intervention is STN-DBS for advanced PD, with six RCTs against best medical treatment BMT [40, 41, 45– 47 ] of which one had a double-blind design [ 47 ].”
Self-citationTransplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease
Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W.-Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. Q., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441002 · Cited by 2,366
Reversal of Experimental Parkinsonism by Lesions of the Subthalamic Nucleus
Bergman, H., Wichmann, T., & DeLong, M. R. (1990) · Science · doi:10.1126/science.2402638 · Cited by 1,907
Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
Limousin, P., Krack, P., Pollak, P., Benazzouz, A., Ardouin, C., Hoffmann, D., & Benabid, A.-L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810153391603 · Cited by 1,853 · cited 1×
“This also includes treatment-resistant tremor.(44) The group is labeled here as advanced PD.”
Weaver, F. M. (2009) · JAMA · doi:10.1001/jama.2008.929 · Cited by 1,525
Neurostimulation for Parkinson's Disease with Early Motor Complications
Schuepbach, W. M. M., Rau, J., Knudsen, K., Volkmann, J., Krack, P., Timmermann, L., Hälbig, T. D., Hesekamp, H., Navarro, S. M., Meier, N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205158 · Cited by 1,430 · cited 2×
“STN-DBS for Early PD with Early Fluctuations Two studies were included in the review.(60,61) Overall, 271 patients with PD aged younger than 60 years and with fluctuations or dyskinesia for less than 3 years were randomly assigned to STN-DBS or BMT.”
Self-citationPallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease
Follett, K. A., Weaver, F. M., Stern, M., Hur, K., Harris, C. L., Luo, P., Marks, W. J., Rothlind, J., Sagher, O., Moy, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907083 · Cited by 1,355 · cited 4×
“A minor improvement of depression in the GPi group was found in the US study [ 43 ].”
InfluentialA double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
Olanow, C. W., Goetz, C. G., Kordower, J. H., Stoessl, A. J., Sossi, V., Brin, M. F., Shannon, K. M., Nauert, G. M., Perl, D. P., Godbold, J., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10720 · Cited by 1,307 · cited 1×
“Human fetal [29, 30] or stem cell transplantation or gene therapy [ 31– 33 ] are experimental treatments of PD and have currently no relevance for clinical care.”
Santesso, N., Glenton, C., Dahm, P., Garner, P., Akl, E. A., Alper, B., Brignardello-Petersen, R., Carrasco-Labra, A., De Beer, H., Hultcrantz, M., et al. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.10.014 · Cited by 1,198 · cited 2×
“The wording of the results follows the suggestions of GRADE (see Table 1).(38) All comparisons of effects and adverse effects are against standard noninvasive treatments (medication).”
A Comparison of Continuous Thalamic Stimulation and Thalamotomy for Suppression of Severe Tremor
Schuurman, P. R., Bosch, D. A., Bossuyt, P. M. M., Bonsel, G. J., van Someren, E. J. W., de Bie, R. M. A., Merkus, M. P., & Speelman, J. D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002173420703 · Cited by 1,044 · cited 2×
“Because of the general impression that DBS results in fewer complications [ 11 ], which was confirmed by a randomized controlled trial in the year 2000 [ 12 ], DBS has become the most frequently used intervention, and lesional procedures have usually been reserved for specific situations.”
Stereotaxic Apparatus for Operations on the Human Brain
Spiegel, E. A., Wycis, H. T., Marks, M., & Lee, A. J. (1947) · Science · doi:10.1126/science.106.2754.349 · Cited by 982 · cited 2×
“Historically, the first invasive treatment for the treatment of advanced PD was radiofrequency thermocoagulation brain surgery, dating back to the 1950s.(13) In the 1990s, localized lesions with radiation were proposed.”
Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes
Kleiner-Fisman, G., Herzog, J., Fisman, D. N., Tamma, F., Lyons, K. E., Pahwa, R., Lang, A. E., & Deuschl, G. (2006) · Movement Disorders · doi:10.1002/mds.20962 · Cited by 957 · cited 1×
“A large number of case series [ 19 ] and finally randomized controlled studies have established the concept of DBS of the STN or the globus pallidus internus (GPi) for the treatment of PD. [ 20] Radiosurgery of the Vim with proton beams has also been used since the late 1960s in few centers…”
Self-citationA Pilot Study of Focused Ultrasound Thalamotomy for Essential Tremor
Elias, W. J., Huss, D., Voss, T., Loomba, J., Khaled, M., Zadicario, E., Frysinger, R. C., Sperling, S. A., Wylie, S., Monteith, S. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300962 · Cited by 875 · cited 1×
“However, radiofrequency thermocoagulation lesions have been progressively abandoned because of better results with DBS or the unavailability of these procedures in many countries.(74,75) The latest and most advanced lesional but incisionless intervention is MRgFUS with few RCTs(74,75) and several uncontrolled studies…”
Odekerken, V. J., van Laar, T., Staal, M. J., Mosch, A., Hoffmann, C. F., Nijssen, P. C., Beute, G. N., van Vugt, J. P., Lenders, M. W., Contarino, M. F., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70264-8 · Cited by 763 · cited 3×
“Duration of the studies was 24 months [ 43 ] and 12 months [ 42 ], respectively.”
Williams, A., Gill, S., Varma, T., Jenkinson, C., Quinn, N., Mitchell, R., Scott, R., Ives, N., Rick, C., Daniels, J., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70093-4 · Cited by 733 · cited 1×
“The most extensively studied intervention is STN-DBS for advanced PD, with six RCTs against best medical treatment BMT [40, 41, 45– 47 ] of which one had a double-blind design [ 47 ].”
Olanow, C. W., Kieburtz, K., Odin, P., Espay, A. J., Standaert, D. G., Fernandez, H. H., Vanagunas, A., Othman, A. A., Widnell, K. L., Robieson, W. Z., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70293-x · Cited by 716
Self-citationLeksell, L. (1983) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.46.9.797 · Cited by 521 · cited 1×
“…randomized controlled studies have established the concept of DBS of the STN or the globus pallidus internus (GPi) for the treatment of PD. [ 20] Radiosurgery of the Vim with proton beams has also been used since the late 1960s in few centers worldwide [21, 22] initially only for this nucleus.”
Applications of focused ultrasound in the brain: from thermoablation to drug delivery
Meng, Y., Hynynen, K., & Lipsman, N. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00418-z · Cited by 505 · cited 2×
“This technique is currently used within the thalamus but lesioning of the STN was also recently reported.(23) Among pharmacological interventions, the concept of reducing dopaminergic hypersensitivity and maintaining constant plasma levels by continuous stimulation of dopaminergic terminals has emerged,(24) resulting…”
EFNS/MDS‐ES recommendations for the diagnosis of Parkinson's disease
Berardelli, A., Wenning, G. K., Antonini, A., Berg, D., Bloem, B. R., Bonifati, V., Brooks, D., Burn, D. J., Colosimo, C., Fanciulli, A., et al. (2013) · European Journal of Neurology · doi:10.1111/ene.12022 · Cited by 489
Self-citationLong-term outcomes of deep brain stimulation in Parkinson disease
Limousin, P., & Foltynie, T. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0145-9 · Cited by 480 · cited 3×
“However, a number of uncontrolled long-term studies of patients with advanced PD and STN stimulation are available and underwent multiple meta-analyses.(52,57,58) These reveal that STN-DBS is still effective beyond 15 years after the intervention, with significant improvement in motor complications and a stable reduct…”
Self-citationRandomized trial of deep brain stimulation for Parkinson disease: Thirty-six-month outcomes
Weaver, F. M., Follett, K. A., Stern, M., Luo, P., Harris, C. L., Hur, K., Marks, W. J., Rothlind, J., Sagher, O., Moy, C., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31825dcdc1 · Cited by 452
Svennilson, E., Torvik, A., Lowe, R., & Leksell, L. (1960) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1960.tb07606.x · Cited by 428
Okun, M. S., Gallo, B. V., Mandybur, G., Jagid, J., Foote, K. D., Revilla, F. J., Alterman, R., Jankovic, J., Simpson, R., Junn, F., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70308-8 · Cited by 409
Bond, A. E., Shah, B. B., Huss, D. S., Dallapiazza, R. F., Warren, A., Harrison, M. B., Sperling, S. A., Wang, X.-Q., Gwinn, R., Witt, J., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3098 · Cited by 373
Ferreira, J. J., Katzenschlager, R., Bloem, B. R., Bonuccelli, U., Burn, D., Deuschl, G., Dietrichs, E., Fabbrini, G., Friedman, A., Kanovsky, P., et al. (2013) · European Journal of Neurology · doi:10.1111/j.1468-1331.2012.03866.x · Cited by 348
Self-citationKatzenschlager, R., Poewe, W., Rascol, O., Trenkwalder, C., Deuschl, G., Chaudhuri, K. R., Henriksen, T., van Laar, T., Spivey, K., Vel, S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30239-4 · Cited by 340 · cited 1×
“One recent RCT with a 12-week double-blind phase and a 52-week open-label phase [ 71 ] was identified.”
Self-citationHorstink, M., Tolosa, E., Bonuccelli, U., Deuschl, G., Friedman, A., Kanovsky, P., Larsen, J. P., Lees, A., Oertel, W., Poewe, W., et al. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01547.x · Cited by 297
Self-citation[Effects of the stimulation of the subthalamic nucleus in Parkinson disease].
Pollak, P., Benabid, A., Gross, C. E., Gao, D. M., Laurent, A., Benazzouz, A., Hoffmann, D., Gentil, M., & Perret, J. E. (1993) · PubMed · Cited by 282
Randomized Trial of Focused Ultrasound Subthalamotomy for Parkinson’s Disease
Martínez-Fernández, R., Máñez-Miró, J. U., Rodríguez-Rojas, R., del Álamo, M., Shah, B. B., Hernández-Fernández, F., Pineda-Pardo, J. A., Monje, M. H. G., Fernández-Rodríguez, B., Sperling, S. A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2016311 · Cited by 282 · cited 1×
“In a controlled trial [ 95 ], 27 patients were randomly assigned to unilateral subthalamotomy and 13 to sham treatment.”
Predictors of effective bilateral subthalamic nucleus stimulation for PD
Charles, P. D., Van Blercom, N., Krack, P., Lee, S. L., Xie, J., Besson, G., Benabid, A.-L., & Pollak, P. (2002) · Neurology · doi:10.1212/wnl.59.6.932 · Cited by 263
GPi vs STN deep brain stimulation for Parkinson disease: Three-year follow-up
Odekerken, V. J. J., Boel, J. A., Schmand, B. A., de Haan, R. J., Figee, M., van den Munckhof, P., Schuurman, P. R., de Bie, R. M. A., For the NSTAPS study group, NSTAPS study group, et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002401 · Cited by 251
Neurosurgery at an earlier stage of Parkinson disease: A randomized, controlled trial
Schüpbach, W. M. M., Maltête, D., Houeto, J. L., du Montcel, S. T., Mallet, L., Welter, M. L., Gargiulo, M., Béhar, C., Bonnet, A. M., Czernecki, V., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000250253.03919.fb · Cited by 244 · cited 1×
“STN-DBS for Early PD with Early Fluctuations Two studies were included in the review.(60,61) Overall, 271 patients with PD aged younger than 60 years and with fluctuations or dyskinesia for less than 3 years were randomly assigned to STN-DBS or BMT.”
Randomized trial of pallidotomy versus medical therapy for Parkinson's disease
Vitek, J. L., Bakay, R. A. E., Freeman, A., Evatt, M., Green, J., McDonald, W., Haber, M., Barnhart, H., Wahlay, N., Triche, S., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10517 · Cited by 243
Bilateral subthalamotomy in Parkinson's disease: initial and long-term response
Alvarez, L. (2005) · Brain · doi:10.1093/brain/awh397 · Cited by 224 · cited 1×
“There is only one larger case series on radiofrequency lesioning of the STN, which concluded acceptable feasibility [84, 85] with an open follow-up [ 86 ].”
Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry
Antonini, A., Poewe, W., Chaudhuri, K. R., Jech, R., Pickut, B., Pirtošek, Z., Szasz, J., Valldeoriola, F., Winkler, C., Bergmann, L., et al. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.09.018 · Cited by 220
Self-citationDeep Brain Stimulation in Movement Disorders: From Experimental Surgery to Evidence‐Based Therapy
Krack, P., Volkmann, J., Tinkhauser, G., & Deuschl, G. (2019) · Movement Disorders · doi:10.1002/mds.27860 · Cited by 217 · cited 7×
“Several invasive interventions for PD have undergone a rapid development, with DBS of the STN and GPi being established treatments for the improvement of motor symptoms and health-related QoL.(20) Further questions on the use of DBS for psychosocial impact and nonmotor symptoms in PD as well as the possible usefulness…”
InfluentialSelf-citationDorsal subthalamotomy for Parkinson's disease
Alvarez, L., Macias, R., Guridi, J., Lopez, G., Alvarez, E., Maragoto, C., Teijeiro, J., Torres, A., Pavon, N., Rodriguez-Oroz, M. C., et al. (2001) · Movement Disorders · doi:10.1002/1531-8257(200101)16:1<72::aid-mds1019>3.0.co;2-6 · Cited by 213 · cited 1×
“There is only one larger case series on radiofrequency lesioning of the STN, which concluded acceptable feasibility [84, 85] with an open follow-up [ 86 ].”
Akinesia in Parkinson's disease
Schwab, R. S., England, A. C., & Peterson, E. (1959) · Neurology · doi:10.1212/wnl.9.1.65 · Cited by 210 · cited 1×
“Apomorphine hydrochloride (apomorphine) has been proposed for the treatment of PD since the 1950s [ 27 ], but it had been used only in a few movement disorder centers since then [25, 28].”
Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression
Schuurman, P. R., Bosch, D. A., Merkus, M. P., & Speelman, J. D. (2008) · Movement Disorders · doi:10.1002/mds.22059 · Cited by 197 · cited 1×
“The higher number of AEs with radiof-requency compared with thalamic DBS for unilateral and particularly for bilateral procedures was shown in a controlled trial [12, 83 ] and was the main reason that this treatment has mostly been abandoned.”
Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
Carbone, F., Djamshidian, A., Seppi, K., & Poewe, W. (2019) · CNS Drugs · doi:10.1007/s40263-019-00661-z · Cited by 190
Self-citationUnilateral pallidotomy in Parkinson's disease: a randomised, single-blind, multicentre trial
de Bie, R. M., de Haan, R. J., Nijssen, P. C., Rutgers, A. W. F., Beute, G. N., Bosch, D. A., Haaxma, R., Schmand, B., Schuurman, P. R., Staal, M. J., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03556-4 · Cited by 177
Horstink, M., Tolosa, E., Bonuccelli, U., Deuschl, G., Friedman, A., Kanovsky, P., Larsen, J. P., Lees, A., Oertel, W., Poewe, W., et al. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01548.x · Cited by 173
Self-citationSubthalamic and pallidal deep brain stimulation for Parkinson’s disease—meta-analysis of outcomes
Lachenmayer, M. L., Mürset, M., Antih, N., Debove, I., Muellner, J., Bompart, M., Schlaeppi, J.-A., Nowacki, A., You, H., Michelis, J., et al. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00223-5 · Cited by 170 · cited 2×
“Maintenance of QoL above the preoperative level has been found for 5 years after surgery despite the natural progression of the disease.(58,59) The GL group concludes that STN-DBS should be offered to eligible patients with PD with medically resistant fluctuations.”
Self-citationÁlvarez, L., Macıás, R., Pavon, N., Lopez, G., Rodríguez-Oroz, M. C., Rodríguez‐Rojas, R., Álvarez, M., Pedroso, I., Teijeiro, J., Fernández, R. G., et al. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.154948 · Cited by 163 · cited 1×
“There is only one larger case series on radiofrequency lesioning of the STN, which concluded acceptable feasibility(84,85) with an open follow-up.(86) It reported some efficacy but also some cases with ongoing surgically induced dyskinesia.”
Kurtis, M. M., Rajah, T., Delgado, L. F., & Dafsari, H. S. (2017) · npj Parkinson's Disease · doi:10.1038/npjparkd.2016.24 · Cited by 158
Deep brain stimulation in early-stage Parkinson disease
Hacker, M. L., Turchan, M., Heusinkveld, L. E., Currie, A. D., Millan, S. H., Molinari, A. L., Konrad, P. E., Davis, T. L., Phibbs, F. T., Hedera, P., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009946 · Cited by 157
Bove, F., Mulas, D., Cavallieri, F., Castrioto, A., Chabardès, S., Meoni, S., Schmitt, E., Bichon, A., Stasio, E. D., Kistner, A., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012246 · Cited by 156 · cited 2×
“These reveal that STN-DBS is still effective beyond 15 years after the intervention, with significant improvement in motor complications and a stable reduction of dopaminergic drugs [ 59 ].”
Self-citationVitek, J. L., Jain, R., Chen, L., Tröster, A. I., Schrock, L. E., House, P. A., Giroux, M. L., Hebb, A. O., Farris, S. M., Whiting, D. M., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30108-3 · Cited by 153 · cited 1×
“The most extensively studied intervention is STN-DBS for advanced PD, with six RCTs against best medical treatment BMT [40, 41, 45– 47 ] of which one had a double-blind design [ 47 ].”
Rationale for continuous dopaminomimetic therapy of Parkinson's disease.
Chase, T. N., Baronti, F., Fabbrini, G., Heuser, I. J. E., Juncos, J. L., & Mouradian, M. M. (1989) · PubMed · Cited by 152
Self-citationA prospective single-blind study of Gamma Knife thalamotomy for tremor
Witjas, T., Carron, R., Krack, P., Eusebio, A., Vaugoyeau, M., Hariz, M., Azulay, J. P., & Régis, J. (2015) · Neurology · doi:10.1212/wnl.0000000000002087 · Cited by 146 · cited 1×
“One study used blinded evaluation outcomes [ 88 ].”
Deuschl, G., & Agid, Y. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70151-0 · Cited by 141 · cited 1×
“However, a number of uncontrolled long-term studies of patients with advanced PD and STN stimulation are available and underwent multiple meta-analyses [52, 57, 58].”
Self-citationWeintraub, D., Duda, J. E., Carlson, K., Luo, P., Sagher, O., Stern, M., Follett, K. A., Reda, D., Weaver, F. M., & for the CSP 468 Study Group (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304396 · Cited by 135 · cited 1×
“[48, 49] but rates in the treated group do not differ from the comparator group on BMT [ 49 ] suggesting that this is not an effect of the treatment.”
Stereotaxis in Parkinson Syndrome
Hassler, R., Mundinger, F., & Riechert, T. (1979) · doi:10.1007/978-3-642-66521-9 · Cited by 133
Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease
Charles, D., Konrad, P. E., Neimat, J. S., Molinari, A. L., Tramontana, M. G., Finder, S. G., Gill, C. E., Bliton, M. J., Kao, C., Phibbs, F. T., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.03.019 · Cited by 132 · cited 1×
“The study published by Charles and colleagues [64, 65] is the only study on implantation of STN-DBS at a stage where fluctuations have not yet occurred.”
Jung, N. Y., Park, C. K., Kim, M., Lee, P. H., Sohn, Y. H., & Chang, J. W. (2018) · Journal of neurosurgery · doi:10.3171/2018.2.jns172514 · Cited by 129 · cited 1×
“Only one small case series has been published so far.(94) These GLs do not recommend the treatment because appropriate data are lacking.”
Alomar, S. A., King, N. K. K., Tam, J., Bari, A., Hamani, C., & Lozano, A. M. (2017) · Movement Disorders · doi:10.1002/mds.26924 · Cited by 127 · cited 1×
“Bilateral application had the disadvantage of frequent dysarthria in up to 40% of the patients [ 82 ] and it has, therefore, only been applied since the second half of the last century.”
Brain targets in surgery for Parkinson's disease: Results of a survey of neurosurgeons
Laitinen, L. V. (1985) · Journal of neurosurgery · doi:10.3171/jns.1985.62.3.0349 · Cited by 126
Benabid, A., Pollak, P., Hommel, M., Gaio, J. M., Rougemont, J., & Perret, J. E. (1989) · PubMed · Cited by 126
Cost‐effectiveness of focused ultrasound, radiosurgery, and DBS for essential tremor
Ravikumar, V. K., Parker, J. J., Hornbeck, T. S., Santini, V. E., Butts, K., Wintermark, M., Ghanouni, P., Stein, S. C., & Halpern, C. H. (2017) · Movement Disorders · doi:10.1002/mds.26997 · Cited by 117
Complications of Gamma Knife Surgery for Parkinson Disease
Okun, M. S., Stover, N. P., Subramanian, T., Gearing, M., Wainer, B. H., Holder, C. A., Watts, R. L., Juncos, J. L., Freeman, A., Evatt, M. L., et al. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1995 · Cited by 115
Baron, M. S., Vitek, J. L., Bakay, R. A. E., Green, J., McDonald, W. M., Cole, S. A., & DeLong, M. R. (2000) · Movement Disorders · Cited by 114
Cost‐effectiveness of deep brain stimulation in patients with Parkinson's disease
Dams, J., Siebert, U., Bornschein, B., Volkmann, J., Deuschl, G., Oertel, W. H., Dodel, R. C., & Reese, J. (2013) · Movement Disorders · doi:10.1002/mds.25407 · Cited by 106
Self-citationNilsson, D., Hansson, L.-E., Johansson, K., Nyström, C., Paalzow, L., & Aquilonius, S. M. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1998.tb00633.x · Cited by 105 · cited 1×
“Among pharmacological interventions, the concept of reducing dopaminergic hypersensitivity and maintaining constant plasma levels by continuous stimulation of dopaminergic terminals has emerged,(24) resulting in the treatments of continuous subcutaneous infusion of apomorphine(25) or intrajejunal application of L-dopa…”
Long‐term safety and efficacy of levodopa‐carbidopa intestinal gel in advanced Parkinson's disease
Fernandez, H. H., Boyd, J. T., Fung, V. S. C., Lew, M., Rodriguez, R. L., Slevin, J. T., Standaert, D. G., Zadikoff, C., Vanagunas, A. D., Chatamra, K., et al. (2018) · Movement Disorders · doi:10.1002/mds.27338 · Cited by 100 · cited 1×
“SAEs have not only been reported in the controlled study but also in open-label studies, including even life-threatening complications.(69,70) The GL group concluded that the treatment can be considered for people with advanced PD and disabling fluctuations but knowledge about the treatment results beyond 3 months is…”
Stibe, C., Lees, A. J., & STERN, G. M. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91660-6 · Cited by 98 · cited 2×
“…and maintaining constant plasma levels by continuous stimulation of dopaminergic terminals has emerged [ 24 ], resulting in the treatments of continuous subcutaneous infusion of apomorphine [ 25 ] or intrajejunal application of l - dopa– carbidopa intestinal gel (LCIG) preparations [ 26 ].”
Dafsari, H. S., Silverdale, M., Strack, M., Rizos, A., Ashkan, K., Mahlstedt, P., Sachse, L., Steffen, J. K., Dembek, T. A., Visser-Vandewalle, V. E. R. M., et al. (2018) · Movement Disorders · doi:10.1002/mds.27283 · Cited by 98
Self-citationQuality of life predicts outcome of deep brain stimulation in early Parkinson disease
Schüpbach, M. W. M., Tonder, L., Schnitzler, A., Krack, P., Rau, J., Hartmann, A., Hälbig, T. D., Pineau, F., Falk, A., Paschen, L., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007037 · Cited by 98 · cited 1×
“A secondary analysis showed that the effect on QoL depends on the baseline PDQ-39 score, with those having a worse PDQ-39 baseline score having better postoperative improvement.(63) Thus, a subjectively relevant affection of QoL might be a further inclusion criterion.”
Self-citationUnilateral magnetic resonance–guided focused ultrasound pallidotomy for Parkinson disease
Na, Y. C., Chang, W. S., Jung, H. H., Kweon, E. J., & Chang, J. W. (2015) · Neurology · doi:10.1212/wnl.0000000000001826 · Cited by 96
Eggington, S., Valldeoriola, F., Chaudhuri, К. R., Ashkan, K., Annoni, E., & Deuschl, G. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7148-z · Cited by 94
Self-citationSUBCUTANEOUS APOMORPHINE IN PARKINSON'S DISEASE
Poewe, W. H., Kleedorfer, B., Gerstenbrand, F., & Oertel, W. H. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91755-2 · Cited by 93
Christine, C. W., Richardson, R. M., Van Laar, A. D., Thompson, M. E., Fine, E. M., Khwaja, O. S., Li, C., Liang, G. S., Meier, A., Roberts, E. W., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000012952 · Cited by 89
An analysis of the spontaneous rhythmic and non-rhythmic burst discharges in the human thalamus
Ohye, C., Saito, Y., Fukamachi, A., & Narabayashi, H. (1974) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(74)90249-4 · Cited by 83 · cited 1×
“…brain stimulation (DBS), pump therapies, and lesional therapies for the treatment of PD. Radiofrequency thermocoagulation of the thalamus and pallidus internus has a long history of treatment for PD. Initiated in the 1950s [ 6 ], it was practiced around the world in the following decades [ 7– 10 ].”
Deep Brain Stimulation for Freezing of Gait in Parkinson's Disease With Early Motor Complications
Barbe, M. T., Tonder, L., Krack, P., Debu, B. H. G., Schüpbach, M. W. M., Paschen, S., Dembek, T. A., Kühn, A. A., Fraix, V., Brefel‐Courbon, C., et al. (2019) · Movement Disorders · doi:10.1002/mds.27892 · Cited by 74
Self-citationJost, S. T., Sauerbier, A., Visser-Vandewalle, V. E. R. M., Ashkan, K., Silverdale, M., Evans, J., Loehrer, P. A., Rizos, A., Petry‐Schmelzer, J. N., Reker, P., et al. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-322614 · Cited by 69 · cited 1×
“An open 3-year study in 67 STN-DBS patients matched with 84 medically treated patients showed significant differences on the nonmotor symptom scale, particularly for sleep, fatigue, and urinary symptoms.(55) Long-term outcome of STN-DBS cannot be assessed in randomized controlled studies.”
Self-citationSurgical treatments for essential tremor
Elble, R. J., Shih, L. C., & Cozzens, J. W. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1445526 · Cited by 57 · cited 6×
“Limited research activity is available for radiosurgery for PD.(102) No randomized controlled studies on lesional procedures with radiofrequency thermocoagulation have been published, and this treatment may remain a last resort treatment for special cases in the hands of experienced specialized functional neurosurgeon…”
InfluentialFundament, T., Eldridge, P. R., Green, A. L., Whone, A. L., Taylor, R. S., Williams, A. C., & Schüpbach, M. W. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159340 · Cited by 56
Leone, M. A., Keindl, M., Schapira, A. H., Deuschl, G., & Federico, A. (2015) · European Journal of Neurology · doi:10.1111/ene.12818 · Cited by 46 · cited 2×
“The methodology for the development of these GLs has followed the framework provided by GRADE(36) and the recommendations of the EAN on the development of a neurological management GL.(5) Population/ intervention/comparison/outcome (PICO) questions were constructed according to GRADE standards and are shown in the App…”
Self-citationSubthalamotomy for Parkinson’s disease: clinical outcome and topography of lesions
Rodríguez‐Rojas, R., Carballo-Barreda, M., Alvarez, L. M., Guridi, J., Fuentes, N. P., García-Maeso, I., Macías, R. J., Rodríguez-Oroz, M. C., & Obeso, J. A. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316241 · Cited by 44
Stroupe, K. T., Weaver, F. M., Cao, L., Ippolito, D., Barton, B. R., Burnett‐Zeigler, I., Holloway, R. G., Vickrey, B. G., Simuni, T., & Follett, K. A. (2014) · Movement Disorders · doi:10.1002/mds.26029 · Cited by 41
Cost-Effectiveness of Device-Aided Therapies in Parkinson’s Disease: A Structured Review
Śmiłowska, K., van Wamelen, D. J., Pietrzykowski, T., Calvano, A., Rodríguez‐Blázquez, C., Martínez‐Martín, P., Odin, P., & Chaudhuri, К. R. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202348 · Cited by 37 · cited 2×
“Health economics and cost-effectiveness of those interventions are beyond the scope of these GLs, but existing systematic reviews are available.(35)”
Self-citationComparing two randomized deep brain stimulation trials for Parkinson’s disease
Deuschl, G., Follett, K. A., Luo, P., Rau, J., Weaver, F. M., Paschen, S., Steigerwald, F., Tonder, L., Stoker, V., & Reda, D. J. (2019) · Journal of neurosurgery · doi:10.3171/2018.12.jns182042 · Cited by 34 · cited 1×
“Most studies reported a minimum of 33% improvement as an inclusion criterion, and lower values have shown poorer treatment results [ 51 ].”
Self-citationMeng, Y., Pople, C. B., Kalia, S. K., Kalia, L. V., Davidson, B., Bigioni, L., Li, D. Z., Suppiah, S., Mithani, K., Scantlebury, N., et al. (2020) · Journal of neurosurgery · doi:10.3171/2020.5.jns20692 · Cited by 33 · cited 1×
“Therefore, preliminary data suggesting that MRgFUS may be cost-effective compared with DBS should be interpreted with caution.(96) The majority of people with advanced PD have bilateral disease, but it is unknown whether MRgFUS subthalamotomy can be safely and efficiently performed bilaterally.”
Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease.
Strutt, A., Lai, E., Jankovic, J., Atassi, F., Soety, E., Levin, H., Grossman, R., & York, M. (2009) · Surgical Neurology · doi:10.1016/j.surneu.2008.03.039 · Cited by 32
Psychiatric and social outcome after deep brain stimulation for advanced Parkinson's disease
Boel, J. A., Odekerken, V. J. J., Geurtsen, G. J., Schmand, B. A., Cath, D. C., Figee, M., van den Munckhof, P., de Haan, R. J., Schuurman, P. R., de Bie, R. M. A., et al. (2015) · Movement Disorders · doi:10.1002/mds.26468 · Cited by 22 · cited 1×
“This applies for QoL (PDQ-39), ADLs (UPDRS-II) at 1 and 2 years, motor score (UPDRS-III in the off medication state) at 1 and 2 years, complications of therapy, ON time without troublesome dyskinesia, SAEs, Hoehn and Yahr staging, and cognition.(53,66) A minor improvement of depression in the GPi group was found in th…”
Ferreira, J. J., Katzenschlager, R., Bloem, B. R., Bonuccelli, U., Burn, D., Deuschl, G., Dietrichs, E., Fabbrini, G., Friedman, A., Kanovsky, P., et al. (n.d.) · doi:10.7892/boris.53850 · Cited by 22
Self-citationXu, Y., Yang, B., Zhou, C., Gu, M., Long, J., Wang, F., Zhu, Y., Liu, B., Ren, H. J., & Yang, X. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04555-7 · Cited by 22
GPi vs STN deep brain stimulation for Parkinson disease Three-year follow-up
Odekerken, V. J. J., Boel, J. A., Schmand, B. A., de Haan, R. J., Figee, M., van den Munckhof, P., Schuurman, P. R., de Bie, R. M. A., & Grp, N. S. (2016) · Leiden Repository (Leiden University) · Cited by 18
Aleksovska, K., Bassetti, C. L., Berger, T., Carvalho, V., Costa, J. N., Deuschl, G., Frederiksen, K. S., Jaarsma, J., Kobulashvili, T., Leone, M. A., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.14933 · Cited by 18 · cited 1×
“For each of these interventions, the GL group has worded a clinical consensus statement according to EAN standards.(39) A detailed protocol of the GL development can be found in the full GLs (see the online attachment).”
Self-citationGene therapy for Parkinson disease—a hope, or a dream?
Olanow, C. W. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.45 · Cited by 16
Intraneuronal implants enable long-term tactile sensation in patients with hand amputation
Ridler, C. E. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0122-8 · Cited by 3
Cited by
Tanner, C. M., & Ostrem, J. L. (2024) · New England Journal of Medicine · doi:10.1056/nejmra2401857 · Cited by 382
Hanlon, C. A., Lench, D. H., Pell, G., Roth, Y., Zangen, A., & Tendler, A. (2024) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1336027 · Cited by 7
Metadata
- Authors
- Deuschl, G., Antonini, A., Costa, J., Śmiłowska, K., Berg, D., Corvol, J., Fabbrini, G., Ferreira, J., Foltynie, T., Mir, P., Schrag, A., Seppi, K., Taba, P., Ruzicka, E., Selikhova, M., Henschke, N., Villanueva, G., & Moro, E.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2022-07
- Volume
- 37
- Issue
- 7
- Pages
- 1360-1374
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W4283834705
- Cited by
- 190
- References
- 92
- FWCI
- 17.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.